Autonomic Nervous System Drugs Practice Questions

Q: Which statement is true regarding dobutamine?

Dobutamine decreases peripheral resistance.. **Explanation:** Dobutamine is a synthetic catecholamine primarily used as a positive inotropic agent. Its pharmacological profile is unique due to its action on multiple adrenergic receptors. **1. Why Option A is correct:** Dobutamine is a relatively selective **$\beta_1$-agonist**, but it also possesses activity at $\beta_2$ and $\alpha_1$ receptors. While its $\beta_1$ effect increases cardiac output, its **$\beta_2$-agonist activity** leads to vasodilation in the skeletal muscle vascular bed. This results in a **decrease in total peripheral resistance (TPR)**. Although it has some $\alpha_1$ agonist activity (which causes vasoconstriction), the $\beta_2$ effect usually predominates or balances it out, leading to a net reduction in afterload. **2. Why the other options are incorrect:** * **Option B:** Unlike dopamine, dobutamine **does not act on Dopaminergic (D1 or D2) receptors**. It is purely an adrenergic agonist. * **Option C:** Dobutamine generally **increases renal blood flow**. This is not due to direct D1 stimulation (like dopamine), but rather a secondary effect of increased cardiac output and improved systemic hemodynamics. * **Option D:** Dobutamine **increases coronary blood flow** due to increased cardiac work and secondary metabolic vasodilation, as well as direct $\beta_2$ effects on coronary vessels. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dobutamine is the preferred inotrope for **Cardiogenic Shock** (without severe hypotension) and **Acute Decompensated Heart Failure**. * **Dobutamine Stress Echo:** Used to diagnose ischemic heart disease in patients unable to exercise; it increases myocardial oxygen demand to reveal wall motion abnormalities. * **Isomeric property:** The (+)-isomer is a powerful $\beta$ agonist, while the (-)-isomer is an $\alpha_1$ agonist. In clinical racemic mixtures, the $\beta$ effects predominate.

Q: Agonistic action at which of the following adrenergic receptors results in the reduction of excess secretion?

Alpha 2 receptor. The correct answer is **Alpha 2 receptor (D)**. This question tests the understanding of the autonomic nervous system's regulatory mechanisms, specifically **presynaptic inhibition**. **Why Alpha 2 is correct:** Alpha 2 ($\alpha_2$) receptors are primarily located on the **presynaptic nerve terminals**. They function as "autoreceptors" that provide a negative feedback loop. When an agonist binds to these receptors, it inhibits the further release of neurotransmitters (like norepinephrine and acetylcholine) from the nerve endings [1]. By reducing the release of these neurotransmitters, $\alpha_2$ agonism effectively leads to a **reduction in glandular secretions** and sympathetic outflow. **Why the other options are incorrect:** * **Beta 1 ($\beta_1$):** These are primarily found in the heart. Agonism leads to increased heart rate (chronotropy) and contractility (inotropy), rather than a reduction in secretions. * **Beta 2 ($\beta_2$):** Agonism here typically causes smooth muscle relaxation (bronchodilation, vasodilation) and can actually increase certain secretions (e.g., aqueous humor in the eye). * **M2 receptor:** While these are inhibitory receptors found in the heart (slowing the heart rate), they are **muscarinic**, not adrenergic receptors as specified by the question's context of "adrenergic receptors." **High-Yield NEET-PG Pearls:** * **Clonidine and Dexmedetomidine** are classic $\alpha_2$ agonists used clinically to reduce sympathetic tone and provide sedation/analgesia. * **Apraclonidine/Brimonidine** ($\alpha_2$ agonists) are used in glaucoma specifically because they **reduce the secretion** of aqueous humor. * Remember: $\alpha_1$ is generally excitatory (postsynaptic), while $\alpha_2$ is generally inhibitory (presynaptic).

Q: What is the preferred preoperative drug for managing blood pressure in a patient with pheochromocytoma?

Phenoxybenzamine. ***Phenoxybenzamine***- It is the standard first-line agent, administered 10–14 days preoperatively, because it is a **non-selective**, **irreversible alpha-adrenergic blocker**.- This irreversible blockade prevents the high concentrations of circulating **catecholamines** (epinephrine and norepinephrine) resulting in severe **hypertensive crisis** during surgical tumor manipulation.*Propranolol*- Propranolol and other pure **beta-blockers** should only be initiated *after* adequate **alpha-blockade** is established, typically to control tachycardia.- Giving a beta-blocker alone leaves the **alpha-1 receptors** unopposed, leading to unchecked systemic **vasoconstriction** and severe, potentially fatal, hypertension.*Prazosin*- Although Prazosin is an **alpha-1 selective blocker**, it is generally less preferred because it is a *reversible* antagonist.- **Phenoxybenzamine** is favored because its irreversible action provides superior, more stable, and prolonged protection against massive **catecholamine surges** during surgery.*Labetalol*- Labetalol is generally avoided for initial control because its **beta-blocking action** significantly outweighs its alpha-blocking action (high beta:alpha ratio).- This dominant beta blockade can induce **unopposed alpha vasoconstriction**, similar to pure beta-blockers, resulting in paradoxical and severe **hypertension**.

Q: Mechanism of action of botulinum toxin is:

Inhibits the release of acetylcholine. ***Inhibits the release of Acetylcholine***- Botulinum toxin (BoNT) is a **zinc metalloprotease** that cleaves **SNARE proteins** (e.g., SNAP-25) essential for vesicular fusion and neurotransmitter release.- By preventing the exocytosis of **acetylcholine (ACh)** vesicles at the **neuromuscular junction**, BoNT causes irreversible chemical denervation and resulting **flaccid paralysis**.*Inhibits Elongation factor 2*- Inhibition of **Elongation factor 2 (EF-2)** targets the host cell's **protein synthesis** machinery, leading to cell death.- This mechanism is characteristic of toxins like **Diphtheria toxin** and *Pseudomonas aeruginosa* **Exotoxin A**, not botulinum toxin.*Inhibits the release of GABA*- While BoNT can inhibit the release of various neurotransmitters, its defining clinical effect of **flaccid paralysis** is primarily due to inhibition of **acetylcholine** at the peripheral neuromuscular junction.- Inhibition of **GABA** (an inhibitory neurotransmitter) in the CNS would typically lead to increased CNS excitability or spasms, which is contrary to the effects of botulism.*Increases cAMP*- Increasing intracellular **cAMP** levels, usually via activation of **adenylate cyclase**, is the mechanism used by toxins such as **cholera toxin** and **pertussis toxin**.- This mechanism primarily causes large fluid shifts (diarrhea) or cellular dysfunction (like impaired phagocytosis) and is unrelated to botulinum toxin's paralytic action.

Q: Which of the following conditions is not reversed with the administration of atropine?

Muscle weakness due to neuromuscular blockade. ***Muscle weakness due to neuromuscular blockade*** - Atropine is a **muscarinic receptor antagonist** and therefore has no direct effect on the **nicotinic receptors** responsible for neuromuscular transmission and muscle strength. - The reversal of **non-depolarizing neuromuscular blockade** requires increasing acetylcholine via a **cholinesterase inhibitor** (e.g., neostigmine), which acts at the **neuromuscular junction**. *Bradycardia* - Atropine blocks **M2 receptors** on the heart's sinoatrial (SA) node, inhibiting **vagal tone** and increasing the heart rate, thereby reversing bradycardia. - It is the primary drug used to treat hemodynamically significant **bradyarrhythmias**. *Excessive salivation* - Atropine is an anticholinergic agent that blocks **M3 receptors** on exocrine glands, effectively reducing all secretions, including **saliva**. - This is why it is often used as a pre-anesthetic agent to dry secretions and reduce the risk of **aspiration**. *Bronchoconstriction* - Atropine blocks **M3 receptors** in the bronchial smooth muscle, leading to relaxation and **bronchodilation**. - While effective, related synthetic compounds like **ipratropium** are often preferred for treating bronchoconstriction due to fewer systemic anticholinergic side effects.

Q: Which drug elicits the following response on blood pressure and heart rate, as shown in the image?

Norepinephrine. ***Norepinephrine*** - Norepinephrine is a potent agonist at **α1** and **β1** receptors with minimal **β2** activity. The strong **α1** stimulation causes intense vasoconstriction, leading to a marked increase in systolic, diastolic, and mean arterial pressure, as seen in the graph. - Although norepinephrine directly stimulates the heart via **β1** receptors, the significant rise in blood pressure activates the **baroreceptor reflex**. This reflex increases vagal tone, which overrides the direct chronotropic effect and results in a net decrease in heart rate (reflex bradycardia). *Isoproterenol* - Isoproterenol is a non-selective **β-agonist** (**β1** and **β2**) and lacks **α-agonist** effects. It would cause a significant increase in heart rate (**β1** effect). - Its potent **β2** receptor stimulation leads to vasodilation and a *decrease* in diastolic and mean arterial pressure, which is the opposite of the response shown. *Epinephrine* - Epinephrine stimulates **α1**, **β1**, and **β2** receptors. At typical doses, the direct **β1** effect increases the heart rate, and the **β2** effect partially counteracts **α1**-mediated vasoconstriction, leading to a smaller rise in diastolic pressure. - The pronounced reflex bradycardia and significant increase in both systolic and diastolic pressure are more characteristic of norepinephrine's lack of **β2** agonism. *Dopamine* - Dopamine's effects are dose-dependent. At pressor doses (high doses) that stimulate **α1** receptors to increase blood pressure, there is also significant **β1** receptor stimulation. - The concurrent **β1** stimulation typically causes tachycardia or prevents significant reflex bradycardia, which is inconsistent with the graph showing a decreased heart rate.

Question 1

Which statement is true regarding dobutamine?

Accepted Answer

Dobutamine decreases peripheral resistance.

Answer

Dobutamine acts on D1 and D2 receptors.

Answer

Dobutamine decreases kidney circulation.

Answer

Dobutamine has no effect on coronary circulation.

Question 2

Dobutamine differs from dopamine in which of the following ways?

Accepted Answer

It does not activate peripheral dopaminergic receptors.

Answer

It has good blood-brain barrier penetrability.

Answer

It causes pronounced tachycardia.

Answer

It does not activate adrenergic beta receptors.

Question 3

Bradycardia is seen with which of the following drugs?

Accepted Answer

Succinylcholine

Answer

Midazolam

Answer

Epinephrine

Answer

Dopamine

Question 4

Agonistic action at which of the following adrenergic receptors results in the reduction of excess secretion?

Accepted Answer

Alpha 2 receptor

Answer

Beta 1 receptor

Answer

Beta 2 receptor

Answer

M2 receptor

Question 5

What is the preferred preoperative drug for managing blood pressure in a patient with pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Prazosin

Answer

Propranolol

Answer

Labetalol

Question 6

Mechanism of action of botulinum toxin is:

Accepted Answer

Inhibits the release of acetylcholine

Answer

Increases cAMP

Answer

Inhibits the release of GABA

Answer

Inhibits Elongation Factor 2

Question 7

What is the mechanism of action of botulinum toxin?

Accepted Answer

Inhibits acetylcholine release from the presynaptic terminal

Answer

Blocks the postsynaptic acetylcholine receptor

Answer

Inhibits acetylcholine reuptake

Answer

Inhibits acetylcholinesterase

Question 8

Which of the following conditions is not reversed with the administration of atropine?

Accepted Answer

Muscle weakness due to neuromuscular blockade

Answer

Bradycardia

Answer

Bronchoconstriction

Answer

Excessive salivation

Question 9

The most appropriate description of the vasomotor reversal of Dale is that

Accepted Answer

A patient pretreated with phentolamine develops severe hypotension on the administration of adrenaline

Answer

Repeated administration of ephedrine decreases its effect on blood pressure

Answer

An increase in pulse pressure is produced by the intravenous administration of isoprenaline

Answer

High dose of acetylcholine after alpha blockade produces vasomotor reversal

Question 10

Which drug elicits the following response on blood pressure and heart rate, as shown in the image?

Accepted Answer

Norepinephrine

Answer

Epinephrine

Answer

Dopamine

Answer

Isoproterenol

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?